Skip to content

Dr Sophie WILVERS: what changed

BE 0754.903.587NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€19,555
2024 · -€64,451+€84,006
Equity
€17,025
2024 · -€2,530+€19,555
Cash
€54,477
2024 · €37,870+€16,607
Balance sheet total
€57,718
2024 · €46,107+€11,611

Largest movements

2024 to 2025
Assets
  • Cash +€16,607

    up €16,607 (+43.9%), from €37,870 to €54,477

    mainly Net result for the year (+€19,555) and Depreciation (+€7,048)

  • Intangible fixed assets -€6,137

    no longer reported in 2025; in 2024 it stood at €6,137

  • Receivables within one year +€1,841

    first reported in 2025, at €1,841

  • Tangible fixed assets -€911

    no longer reported in 2025; in 2024 it stood at €911

Equity and liabilities
  • Profit (loss) carried forward +€19,555

    up €19,555, from -€7,530 to €12,025

  • Other debts -€7,947

    down €7,947 (-16.4%), from €48,564 to €40,617

Income statement
  • Financial charges -€59,055

    down €59,055 (-99.5%), from €59,330 to €276

  • Gross operating margin +€23,050

    up €23,050 (+510%), from €4,523 to €27,572

  • Depreciation -€2,319

    down €2,319 (-24.8%), from €9,366 to €7,048

  • Financial income -€396

    no longer reported in 2025; in 2024 it stood at €396

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€64,451
Gross operating margin +€23,050
Depreciation +€2,319
Other operating charges -€22
Financial income -€396
Financial charges +€59,055
Result 2025 €19,555
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€16,607
Investment €0
Financing €0
Cash 2024 €37,870
Net result for the year +€19,555
Depreciation +€7,048
Receivables within one year -€1,841
Deferred charges and accrued income -€211
Trade debts +€4
Other debts -€7,947
Cash 2025 €54,477
brings cash intakes cash out
Every line side by side 30 lines
Line Code 2024 2025 Change %
Total assets 20/58 €46,107 €57,718 +€11,611 +25.2%
Fixed assets 21/28 €7,048 - -€7,048
Intangible fixed assets 21 €6,137 - -€6,137
Tangible fixed assets 22/27 €911 - -€911
Furniture and vehicles 24 €911 - -€911
Current assets 29/58 €39,059 €57,718 +€18,658 +47.8%
Amounts receivable within one year 40/41 - €1,841 +€1,841
Trade receivables 40 - €1,841 +€1,841
Cash at bank and in hand 54/58 €37,870 €54,477 +€16,607 +43.9%
Deferred charges and accrued income 490/1 €1,190 €1,400 +€211 +17.7%
Total equity and liabilities 10/49 €46,107 €57,718 +€11,611 +25.2%
Equity 10/15 -€2,530 €17,025 +€19,555
Contributions 10/11 €5,000 €5,000 = 0.0%
Profit (loss) carried forward 14 -€7,530 €12,025 +€19,555
Amounts payable 17/49 €48,637 €40,693 -€7,944 -16.3%
Amounts payable within one year 42/48 €48,637 €40,693 -€7,944 -16.3%
Trade debts 44 €72 €76 +€4 +5.0%
Suppliers 440/4 €72 €76 +€4 +5.0%
Other amounts payable 47/48 €48,564 €40,617 -€7,947 -16.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,366 €7,048 -€2,319 -24.8%
Other operating charges 640/8 €673 €695 +€22 +3.3%
Gross operating margin 9900 €4,523 €27,572 +€23,050 +510%
Operating profit (loss) 9901 -€5,516 €19,830 +€25,347
Financial income 75/76B €396 - -€396
Recurring financial income 75 €396 - -€396
Financial charges 65/66B €59,330 €276 -€59,055 -99.5%
Recurring financial charges 65 €59,330 €276 -€59,055 -99.5%
Profit (loss) for the period before taxes 9903 -€64,451 €19,555 +€84,006
Profit (loss) for the period 9904 -€64,451 €19,555 +€84,006
Profit (loss) for the period to be appropriated 9905 -€64,451 €19,555 +€84,006

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€17,025 to €17,025

Midpoint €17,025 · adjusted equity only

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €17,025
Indication €17,025

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€17,025
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€17,025

Capitalised earnings

net result for the year (9904)
2025
€19,555
2024
-€64,451
2023
€20,674
2022
€1,760
excluding non-recurring income and charges
€1,961
2021
€34,487
Average result
-€8,074
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.